Position in SIGA
as of Mar 31, 2026
· filed Apr 6, 2026
Position Value
$1,915
-$34 QoQ
Shares Held
358
+12.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SIGA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GAMMA Investing LLC holds $6,662,328 across 41 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,769 | $958,497 | |
| 2 | ZTS |
Zoetis Inc.
|
12,047 | $865,697 | |
| 3 | VTRS |
Viatris Inc
|
43,632 | $692,876 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
3,714 | $625,957 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,361 | $384,910 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
3,348 | $371,427 | |
| 7 | ALKS |
Alkermes plc.
|
6,705 | $351,308 | |
| 8 | HLN |
Haleon plc
|
34,810 | $324,777 |
All Filings in SIGA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,915 | 358 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | $1,949 | 319 | Shares | Defined | 2026-01-05 | |
| 2025-09-30 | $2,918 | 319 | Shares | Defined | 2025-10-02 | |
| 2025-06-30 | $2,405 | 369 | Shares | Defined | 2025-07-14 | |
| 2024-12-31 | $823 | 137 | Shares | Defined | 2025-01-03 | |
| 2024-09-30 | $945 | 140 | Shares | Defined | 2024-10-07 | |
| 2024-06-30 | $1,062 | 140 | Shares | Defined | 2024-07-02 | |
| No filing history on record for this holder in this stock. | ||||||